GlaxoSmithKline's customized "red wine" drug potent in mice

piggy submitted, created time 2 weeks 1 day (www.reuters.com)

LONDON (Reuters) - A drug in development that mimics a health-boosting compound found in red wine may be a powerful weapon in the fight against obesity and diabetes, researchers said on Tuesday.

A study of mice showed that the GlaxoSmithKline drug SRT1720 was about a thousand times more potent than resveratrol in activating an enzyme that helped the animals burn more energy and lower their insulin and glucose levels

Submit comment | Blog It | Email It | Keywords: insulin metabolism resveratrol aging red wine diabetes obesity